Abstract
Of 163 individuals with a diagnosis of heterozygous familial hypercholesterolemia (FH), only one subject was found to be positive for familial defective apo B-100 (FDB). The eight-member kindred ascertained through this subject who presented with both a clinical phenotype of FH and the FDB apo B-100 (Arg3500→-Gln) mutation was studied. Plasma lipid and lipoprotein profiles, apo E phenotypes, apo B gene markers at the 3′ hypervariable region and LDL-receptor haplotypes (ApaLI, PvuII, NcoI), were determined, together with LDL-receptor activity on freshly isolated blood lymphocytes. The FDB mutation, present in four relatives, was associated with three different phenotypes: FH and severe hypercholesterolemia, moderate hypercholesterolemia and normolipidemia. The FH phenotype occurred in the absence of any functional LDL-receptor defect. In homozygotes for the absence of the PvuII cutting site who had the apo B mutation, LDL-cholesterol levels were low in the presence of the apo E3/2 phenotype and high in the presence of the apo E4/4 phenotype. None of the major known environmental influences accounted for the wide range of variation in LDL-cholesterol among the affected members. Further observations in the spouse and offspring of the normolipidemic FDB subject confirmed the association of apo E4, the FDB mutation and the PvuH(-/-) genotype with high cholesterol levels. It is concluded that the phenotypic expression of the FDB mutation may vary widely as a function of the genetic environment within a family. The presence of phenotypic heterogeneity among individuals with the same apo B mutation may result from epistatic interaction of the apo B locus with genetic factors regulating cholesterol homeostasis, including possible involvement of the apo E and the LDL-receptor gene loci. This study also confirms that the clinical diagnosis of FH is not necessarily associated with an LDL-receptor defect.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
AllainC.C.,PoonL.S.,ChanF.C.S.,RichmondW. andFuP.C. (1974): Enzymatic determination of total serum cholesterol - Clin. Chem.20: 470–475.
BenhamamouchS.,KuznierzJ-P,Agnani G. et al. (1990): Determination of the LDL-receptor binding capacity of human lymphocytes by immunocytofluorimetric assay - Biochim. Biophys. Acta1002: 45–53.
BoenvinkleE.,XiongW.,FourestE. andChanL. (1989): Rapid typing of tandem repeated hypervariable loci by the polymerase chain reaction: application to the apolipoprotein B 3′ hypervariable region - Proc. Natl. Acad. Sci. USA86: 212–216.
BouthillierD.,SingC.F. andDavignonJ. (1983): Apolipoprotein E phenotyping with a single gel method: application to the study of informative matings - J. Lipid Res.24: 1060–1069.
DavignonJ.,Lussier-CacanS.,GattereauA.,MollP.P. andSingC.F. (1983): Interaction of two lipid disorders in a large French-Canadian kindred -Arteriosclerosis3: 13–22.
HeissG.,TamirI.,Davis C.E. et al. (1980): Lipoprotein-cholesterol distributions in selected North-American populations: The Lipid Research Clinic Program Prevalence Study - Circulation61: 302–315.
HumphriesS.E.,KesslingA.M.,Horsthemke B. et al. (1985): A common DNA polymorphism of the low-density lipoprotein receptor, (LDL) receptor gene and its use in diagnosis - Lancet1: 1003–1005
InnerarityT.L.,MahleyR.W.,WeisgraberK.H.,BersotT.P.,KraussR.M.,VegaG.L.,GrundyS.M.,FriedlW.,DavignonJ. andMcCartyB.J. (1990): Familial defective apolipoprotein B-100: A mutation of apolipoprotein B that causes hypercholesterolemia. -J. Lipid Res.31: 1337–1349.
KotzeM.J.,LangenhovenE.,DietzschE. andRetiefA.E. (1987): A RFLP associated with the low-density lipoprotein receptor gene (LDLR)- Nucleic Acids Res.15: 376.
LeitersdorfE.,DobbinE.G.G.,DavignonJ. andHobbsH.H. (1990): Common low-density lipoprotein receptor mutations in the French-Canadian population - J. Clin. Invest.85: 1014–1023.
LeitersdorfE. andHobbsH.H. (1987): Human LDL-receptor gene: two ApaLI RFLPs - Nucleic Acids Res.15: 2782.
Lipid Research Clinics Program - Lipid and lipoprotein analysis (1982): Washington, D.C.: Department of Health, Education and Welfare publ. NIH/75-628, Government Printing Office.
Lussier-CacanS.,BouthillierD. andDavignonJ. (1985): Apo E allele frequency in primary endogenous hypertriglyceridemia (type IV) with and without hyperapobetalipoproteinemia -Arteriosclerosis5: 639–643.
MaY.,BðardC.,RoyM.,DavignonJ. andKesslingA. (1989): Identification of a second “French-Canadian” LDL-receptor gene deletion and a rapid method to detect both deletions - Clin. Genet.36: 219–228.
PedersenJ.C. andBergK. (1989): Interaction between low density lipoprotein receptor (LDLR) and apolipoprotein E (apoE) alleles contributes to normal variation in lipid level - Clin. Genet.35: 331–337.
SampsonE.J.,DemersL.M. andKriegA.F. (1975): Faster enzymatic procedure for serum triglycerides -Clin. Chem.21: 1983–1985.
SchusterH.,RauhG.,KormannB.,HeppT.,HumphriesS.,KellerC.,WolframG. andZöllnerN. (1990): Familial defective apolipoprotein B-100: Comparison with familial hypercholesterolemia in 18 cases detected in Munich - Arteriosclerosis10: 577–581.
SoriaL.F.,LudwigE.H.,ClarkeH.R.G.,VegaG.M.,GrundyS.M. andMcCartyB.J. (1986): Association between a specific apolipoprotein B mutation and familial defective apolipoprotein B-100 - Proc. Natl. Acad. Sci. USA83: 1101–1105.
SouthernE.M. (1975): Detection of specific sequences among DNA fragments separated by gel electrophoresis - J. Mol. Biol.98: 503–517.
Tybærg-HansenA,Gallagher J.,Vincent J.,Houlston R.,Talmud P.,Dunning A.M.,Seed M.,Hamsten A.,Humphries S.E. andMyant N.B. (1990): Familial defective apolipoprotein B-100: detection in the United Kingdom and Scandinavia, and clinical characteristics of ten cases. Atherosclerosis80: 235–242.
UtermannG.,HoppichlerF.,Dieplinger H. et al. (1989): Defects in the low density lipoprotein receptor gene affect lipoprotein (a) levels: Multiplicative interactions of two gene loci associated with premature atherosclerosis - Proc. Natl. Acad. Sci. USA86: 4171–4174.
VegaG.L. andGrundyS.M. (1986): In vivo evidence for reduced binding of low density lipoproteins to receptors as a cause of primary moderate hypercholesterolemia - J. Clin. Invest.78: 1410–1414.
Vu DacN.,MezdourH.,ParraH.J.,LucG.,LuyeyeI. andFruchartJ.C. (1990): A selective bi-site immunoenzymatic procedure for human Lp[a] lipoprotein quantification using monoclonal antibodies against apo [a] and apoB - J. Lipid Res.30: 1437–1443.
Author information
Authors and Affiliations
Additional information
Corresponding author.
Rights and permissions
About this article
Cite this article
Davignon, J., Dufour, R., Roy, M. et al. Phenotypic heterogeneity associated with defective apolipoprotein B-100 and occurrence of the familial hypercholesterolemia phenotype in the absence of an LDL-receptor defect within a Canadian kindred. Eur J Epidemiol 8 (Suppl 1), 10–17 (1992). https://doi.org/10.1007/BF00145344
Issue Date:
DOI: https://doi.org/10.1007/BF00145344